US Patent Issued to EXOGENUS THERAPEUTICS on Dec. 2 for "Compositions comprising small extracellular vesicles derived from umbilical cord blood mononuclear cells with anti-inflammatory and immunomodulatory properties and process for obtaining them" (Portuguese Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,148, issued on Dec. 2, was assigned to EXOGENUS THERAPEUTICS SA (Portugal).

"Compositions comprising small extracellular vesicles derived from umbilical cord blood mononuclear cells with anti-inflammatory and immunomodulatory properties and process for obtaining them" was invented by Joana Correia (Tentugal, Portugal), Renato Cardoso (Luso, Portugal) and Silvia Rodrigues (Matosinhos, Portugal).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a process for isolating Small Extracellular Vesicles secreted by umbilical cord blood mononuclear cells (UCBMNCs) and compositions comprising said Small Extracellular Vesicles, which...